Academic Drug Discovery Conference headed to Music City

Over the past several years, we’ve observed shifting times within the biotech and

Read more

REDCap selected for Life Science TN Venture Pitch

REDCap, a prospective Vanderbilt startup based on a comprehensive electronic data capture (EDC) solution, is one of just five new ventures selected to compete in this year's Life Science TN Venture Pitch Forum.

Read more

New Venture News: EndoInSight wins NSF I-Corps Grant

For Byron Smith, his graduate-level research was personal. After losing his father to cancer, he was eager to explore ways to make colonoscopy less dreaded and increase the number of people who get screened for Colorectal Cancer each year. As his collaborator and former professor Pietro Valdastri quickly pointed out, early screening is key to saving lives.

Read more

2013 Inventor Satisfaction Survey

Vanderbilt Inventors, we need your help! 

Read more

August brings in four new patents

Four new patents protecting Vanderbilt intellectual property were assigned during the month of August. The technologies represent fields such as neuroscience, cellular biology, molecular biology, cancer therapy, and diagnostics. They are: 

Read more

Patent Alert: July activities

Five Vanderbilt inventions received patent protection from the USPTO in July. The technologies represent a variety of fields, including cell biology, molecular biology, cancer therapy, neuroscience, and vaccine production, among others. 

Read more

New Venture News: 100-Day Workout, KaiNexus drive big savings at Vanderbilt

Some powerful work is going on behind the walls of Vanderbilt Children's Hospital Outpatient Center. The Center embarked on a 100-Day Workout to identify ways they could improve internal processes.

Read more

New Venture News: InvisionHeart makes strong pitch at DEMO Day

InvisionHeart CEO Josh Nickols, PhD, had entrepreneurs and investors talking after

Read more

LaunchTN offers help in writing SBIR and STTR grants

Help is here for researchers and entrepreneurs interested in applying for an SBIR or STTR grant (Small Business Innovative Research and Small Business Technology Transfer, respectively).

Read more

VU commercialization efforts are strong in comparison to national trends

The Association of University Technology Managers (AUTM) recently released their Highlights of the latest Annual

Read more

Sign up now for the New Venture Valuation Seminar

UPDATE: This event has been rescheduled for Nov. 1! Keep reading for details.

CTTC will host a New Ventures Valuation seminar in conjunction with the Cool Springs Life Sciences Center. If you have developed valuable technology that you believe might be the basis of a startup and want to understand how they are valued, make plans now to join us and learn more about the valuation process. 

Read more

Glenn Perdue talks valuation vs. price

Earlier this week, a crowd of roughly 40 business men and women, researchers, and entrepreneurs - including a handful from CTTC - listened intently as Glenn Perdue, managing member of Kraft Analytics, LLC and certified valuation analyst, shared insight into the intellectual property and new venture valuation process.

Read more

VU@EC: Engineering student grabs first seat

At just 20 years old, Vanderbilt engineering student Ben Whittle has become the first candidate accepted into the VU@EC program. Whittle and a business partner are developing a new online collaboration platform that will enable groups to brainstorm and share ideas via instant messaging or group video chats, investigate problems, and visualize solutions.  

Read more

New Venture valuation seminar set for July 23

Understanding the valuation of early-stage businesses and related intellectual property is critical for new business ventures.  This information helps determine business strategy, financial modeling and the overall potential for a business.

Read more

KIYATEC signs deal, will explore potential of Vanderbilt technology

Vanderbilt University signed an option and limited license agreement with KIYATEC, a company dedicated to commercializing 3D cell culture technologies.

Read more

What we’ve learned from sequestration

When the sequester hit a few months ago, it hit. Academia and the healthcare industry both took significant punches. U.S. academic medical institutions are collectively facing reductions up to $1 billion, prompting large scale layoffs and implementation of creative cost-saving strategies.

Read more

Vanderbilt-powered startup wins NewME Accelerator PopUp event

BioNanovations, a startup company based on technology developed at Vanderbilt, claimed first place at the NewME Accelerator PopUp event held in Memphis June 28-30.

Read more

Apply NOW! 2013 Life Science Tennessee Venture Forum

A good opportunity for new ventures in the life sciences industry opened today. The second annual Life Science Tennessee Venture Forum is now accepting applications for the 2013 competition.

Read more

Vanderbilt opens space at Entrepreneur Center

Vanderbilt faculty, staff and students with innovative ideas and entrepreneurial aspirations will have additional support during the 2013-14 academic year.

Read more

Collaboration between Vanderbilt and startup Femtometrix leads to exclusive deal

An innovative wafer inspection tool developed by a team of Vanderbilt professors and engineers has been licensed exclusively to startup company Femtometrix. The semiconductor wafer-inspection technology based on laser optics was invented by Norman Tolk, Ph.D., professor of physics, Michael Alles, engineer for Vanderbilt University’s School of Engineering, and Ron Schrimpf, Ph.D., professor of electrical engineering.

Read more

Technology News: Lab on a Chip

The Wall Street Journal recently featured “organs on a chip”, an innovative practice that is helping researchers around the globe dive into a new world of drug discovery.

Read more

Millions of patients now able to benefit from Medicare approved test

Congratulations to a Vanderbilt research collaborator on receiving Medicare approval of a diagnostic test for patients with advanced non-small cell lung cancer (NSCLC).

 

Biodesix, the molecular diagnostic company that owns VeriStrat, shared the news via press release:

Read more

Supreme Court rules human genes are not patentable, synthetic are

 "Supreme Court Says Human Genes Aren’t Patentable,” reads a June 13 headline on the

Read more

The crack down on "patent trolls"

Last week, the Obama Administration announced a string of executive actions and legislative recommendations in an attempt to “protect innovators from frivolous litigation and ensure the highest-quality patents in our system,” as stated in the on

Read more

My Cancer Genome unveils mobile app

The My Cancer Genome mobile app is now available on iTunes! MCG DrugList brings the benefits of the nation’s first online information, personalized cancer decision support tool right to your mobile device. Listed features include:

  • Information about new drugs.
  • Up-to-date lists of anti-cancer drug classes and drug targets.
  • Search for specific drugs or groups of drugs.
  • The ability to save favorite searches and drugs of interest.

Read more

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter